“The Utility of Beta 2 Microglobulin (B2M) as an Initial Diagnostic Tool for Oral Squamous Cell Carcinoma (OSCC): Evidence from a Malaysian Scenario”, Bangladesh J Med Sci, vol. 18, no. 4, pp. 729–735, Aug. 2019, doi: 10.3329/bjms.v18i4.42876.